References

1. Combest WL. Valerian. US Pharmacist 1997;22:62-68.

2. Anonymous. Valerian. Lawrence Review of Natural Products. St. Louis: Facts and Comparisons, 1991.

3. Houghton P. Valerian. Pharm J 1994;253:95-96.

4. United States Pharmacopeial Convention (USP). Valerian. Botanical Monograph Series. Rockville: United States Pharmacopeial Convention, 1998.

5. Klepser TB, Klepser ME. Unsafe and potentially safe herbal therapies. Am J Health Syst Pharm 1999; 56:125-138.

6. Houghton PJ. The scientific basis for the reputed activity of valerian. J Pharm Pharmacol 1999;51:505-512.

7. Natural medicines comprehensive database online, 2004. http:// www.naturaldatabase.com/. Date accessed: June 9, 2006.

8. Heiligenstein E, Guenther G. Over-the-counter psychotropics: a review of melatonin, St. Johns's wort, valerian, and kava-kava. J Am Col Health 1998;46:271-276.

9. Blumenthal M. Valerian root. The complete German Commission E monographs. Austin: American Botanical Council, 1998.

10. Donath F, Quispe S, Diefenbach K, et al. Critical evaluation of the effect of valerian on sleep structure and sleep quality. Pharmacopsychiatry 2000;33:47-53.

11. Leathwood PD, Chauffard F, Heck E, Munoz-Box R. Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav 1982;17:65-71.

12. Leathwood PD, Chauffard F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Med 1985;2:144-148.

13. Balderer G, Borbely AA. Effect of valerian on human sleep. Psychopharmacology 1985;87:406-409.

14. Lindahl O, Lindwall L. Double blind study of a valerian preparation. Pharmacol Biochem Behav 1989;32:1065-1066.

15. Schulz H, Stolz C, Muller J. The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study. Pharmacopsychiatry 1994;27:147-151.

16. Leuschner J, Muller J, Rudmann M. Characterization of the central nervous depressant activity of a commercially available valerian root extract. Arzneim Forsch 1993;43:638-641.

17. Hendriks H, Bos R, Woerdenbag HJ, Köster AS. Central nervous depressant activity of valerenic acid in the mouse. Planta Med 1985;51:28-31.

18. Mennini P, Bernasconi P, Bombardelli E, Morazzoni P. In vitro study on the interaction of extracts and pure compounds from Valeriana officinalis roots with GABA, benzodiazepine and barbiturate receptors in rat brain. Fitoterapia 1993;64:291-300.

19. Cavadas C, Araujo I, Cotrim MD, et al. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAa receptor in rat brain. Arzneim Forsch 1995;45:753-755.

20. Santos MS, Ferreira F, Faro C, et al. The amount of GABA present in aqueous extracts of valerian is sufficient to account for [3H] GABA release in synaptosomes. Planta Med 1994;60:475-476.

21. Santos MS, Ferreira F, Cunha AP, Carvalho AP, Macedo T. An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Med 1994;60:278-279.

22. Wagner J, Wagner ML, Hening WA, Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacother 1998;32:680-691.

23. Tyler VE, ed. The Honest Herbal, 3rd edition, Binghamton: Pharmaceutical Products Press, 1993.

24. Houghton P. The biological activity of valerian and related plants. J Ethnopharmacol 1988;22:121-142.

25. Oshima Y, Matsuoka S, Ohizumi Y. Antidepressant principles of Valerianafauriei roots. Chem Pharmacol Bull 1995;43:169-170.

26. Sakamoto T, Mitani Y, Nakajima K. Psychotropic effevts of Japanese valerian root extract. Chem Pharmacol Bull 1992;40:758-761.

27. Muller SF, Klement S. A combination of valerian and umun balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine 2006;13:383-387.

28. Cropley M, Cave Z, Ellis J, Middleton RW. Effect of kava and valerian on human physiological and psychological responses to mental stress assessed under laboratory conditions. Phytother Res 2002;16:23-27.

29. Kohnen R, Oswald WD. Effects of valerian, propranolol and combinations on activation, performance, and mood of healthy volunteers under social stress conditions. Pharmacopsychiatry 1988;21:477-478.

30. Andreatini R, Sartori VA, Seabra ML, Leite JR. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother Res 2002;16:650-654.

31. Hazelhoff B, Malingre TM, Meijer DKF. Antispasmodic effects of valeriana compounds: and in vivo and in vitro study on the guinea-pig ileum. Arch Int Pharmacodyn 1982;257:274-287.

32. Anderson GD, Elmer GW, Kantor ED, Templeton IE, Vitiello MV. Pharmacokinet-ics of valerenic acid after administration of valerian in healthy subjects. Phytother Res 2005;19:801-803.

33. Czeizel AE, Tomcsik M, Timar L. Teratologic evaluation of 178 infants born to mothers who attempted suicide by drugs during pregnancy. Obstet Gynecol 1997;90:195-201.

34. Czeizel A, Szentesi I, Szekeres H, Molnar G, Glauber A, Bucski P. A study of adverse effects on the progeny after intoxication during pregnancy. Ach Toxicol 1988;62:1-7.

35. Tufik S, Fujita K, Seabra MDV, Leticia LL. Effects of a prolonged administration of valepotriates in rats on the mothers and their offspring. J Ethnopharmacol 1994;41:39-44.

36. Petkov V. Plants with hypotensive, antiatheromatous and coronarodilatating action. Am J Chin Med 1979;7:197-236.

37. Rosecrans Ja, Defeo JJ, Youngken HW. Pharmacological investigation of certain Valeriana officinalis L. extracts. J Pharmaceut Sci 1961;50:240-244.

38. Tortarolo M, Braun R, Hubner GE, Maurer HR. In vitro effects of epoxide-bearing valepotriates on mouse early hematopoietic progenitor cells and human T-lympho-cytes. Arch Toxicol 1982;51:37-42.

39. Bounthanh C, Richert L, Beck JP, Haag-Berrurier M, Anton R. The action of valepotriates on the synthesis of DNA and proteins of cultured hepatoma cells. Planta Med 1983;49:138-142.

40. MacGregor FB, Abernethy VE, Dahabra S, Cobden I, Hayes PC. Hepatotoxicity of herbal remedies. Br Med J 1989;299:1156-1157.

41. Chan TYK, Tang CH, Crichley J. Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian). Postgrad Med J 1995;71:227-228.

42. Chan TYK. An assessment of the delayed effects associated with valerian overdose [letter]. Int J Clin Pharmacol Ther 1999;36:569.

43. Willey LB, Mady SP, Cobaugh DG, Wax PM. Valerian overdose: a case report. Vet Hum Toxicol 1995;37:364-365.

44. Garges HP, Varia I, Doraiswamy PM. Cardiac complications and delirium associated with valerian root withdrawal [letter]. JAMA 1998;280:1566-1567.

45. Andreatini R, Loire JR. Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal. Eur J Pharmacol 1994;260:233-235.

46. Budzinski JW, Foster BC, Vandenhoek S, et al. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commerical herbal extracts and tinctures. Phytomedicine 2000; 7:237-282.

47. Lefebrve T, Foster BC, Drouin CE, Livesey JF, Jordan SA. In vitro activity of commerical valerian root extracts against cytochrome P450 3A4. J Pharm Pharmaceuti Sci 2004; 7:265-273.

48. Donovan JL, DeVane CL, Chavin KD, et al. Multiple night-times doses of valerian (Valeriana officianalis) had minimal effects of Cyp3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metab Dispos 2004; 32:1333-1336.

49. Mkrtchyan A, Panosyan V, Panossian A, Wikman G, Wagner H. A phase I clinical study of Andrographis paniculata fixed combination Kan Jang versus ginseng and valerian on the semen quality of healthy male subjects. Phytomedicine 2005;12:403-409.

Kicking Fear And Anxiety To The Curb

Kicking Fear And Anxiety To The Curb

Kicking Fear And Anxiety To The Curb Can Have Amazing Benefits For Your Life And Success. Learn About Calming Down And Gain Power By Learning Ways To Become Peaceful And Create Amazing Results.

Get My Free Ebook


Post a comment